» Articles » PMID: 20091866

Macroscopic Morphologic Subtypes of Laterally Spreading Colorectal Tumors Showing Distinct Molecular Alterations

Overview
Journal Int J Cancer
Specialty Oncology
Date 2010 Jan 22
PMID 20091866
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances in colonoscopic techniques have resulted in more frequent detection of superficial-type colorectal tumors, that is, laterally spreading tumors (LSTs), although little is known about the characteristic clinical features and genetic alterations of LSTs. To elucidate the molecular characteristics of LSTs, genetic alterations in the KRAS, BRAF and PIK3CA genes and abnormal expression of the p53, beta-catenin and MYC proteins were analyzed using direct DNA sequencing and immunohistochemistry for 50 protruded-type tumors (Protruded), 35 granular-type LSTs (LST-G) and 19 nongranular-type LSTs (LST-NG). In addition, loss of heterozygosity (LOH) close to the adenomatous polyposis coli (APC) gene (5q21) was examined in these tumors. In univariate analyses, significant differences were noted in the percentages with KRAS mutations (Protruded, LST-G, LST-NG = 30.0%, 54.3%, 21.1%, respectively, p = 0.0156), nuclear accumulation of beta-catenin (Protruded, LST-G, LST-NG = 50.0%, 37.1%, 68.4%, respectively, p = 0.0267), expression of MYC (Protruded, LST-G, LST-NG = 26.0%, 17.1%, 42.1%, respectively, p = 0.0456) and LOH at the APC gene locus (Protruded, LST-G, LST-NG = 22.0%, 20.0%, 47.4%, respectively, p = 0.0302). Multivariate analysis demonstrated that the macroscopic subtype of LST was significantly associated with KRAS mutation (for LST-NG: odds ratio [OR] 0.23, 95% CI 0.06-0.90) and nuclear accumulation of beta-catenin (for LST-NG: OR 4.05, 95% CI 1.11-14.8). Our data revealed that the 2 subtypes of LST have different molecular characteristics, suggesting that 2 or more different molecular mechanisms result in colorectal tumors with a similar growth pattern.

Citing Articles

Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review).

Wang C, Zhang H, Liu Y, Wang Y, Hu H, Wang G Oncol Lett. 2023; 25(6):230.

PMID: 37153060 PMC: 10157608. DOI: 10.3892/ol.2023.13816.


Integrated Analysis Identifies Novel Fusion Transcripts in Laterally Spreading Tumors Suggestive of Distinct Etiology Than Colorectal Cancers.

Rai S, Singh M, Srivastava S J Gastrointest Cancer. 2022; 54(3):913-926.

PMID: 36480069 DOI: 10.1007/s12029-022-00881-5.


Methylation of CpG island promoters at , , and in a patient with numerous non-granular type laterally spreading tumors and colorectal cancer: A case report.

Iwaizumi M, Taniguchi T, Kurachi K, Osawa S, Sugimoto K, Baba S Oncol Lett. 2022; 25(1):14.

PMID: 36478906 PMC: 9713776. DOI: 10.3892/ol.2022.13600.


Clinicopathological feature and treatment outcome of patients with colorectal laterally spreading tumors treated by endoscopic submucosal dissection.

Jeong Y, Lee J, Kim S, Seo G, Kim H, Joo Y Intest Res. 2018; 17(1):127-134.

PMID: 30301342 PMC: 6361012. DOI: 10.5217/ir.2018.00075.


Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).

Myung D, Kweon S, Lee J, Shin I, Kim S, Seo G PLoS One. 2017; 12(10):e0184205.

PMID: 28977010 PMC: 5627894. DOI: 10.1371/journal.pone.0184205.